相关实验视频
Updated: Jul 18, 2025
07:43
Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
20.0K
乌罗立B减轻了小鼠的Helicobacter pylori诱导的炎症和氧化应激
Zhihao Yu1,2, Xiangyue Zhang1, Qiao Zhao1
1Key Laboratory of Biological Resource and Ecological Environment of Chinese Education Ministry, College of Life Sciences, Sichuan University, Chengdu, China.
Helicobacter
|August 25, 2023
概括
乌罗立B (UB) 通过减少细菌殖民和炎症,有效地对抗Helicobacter pylori感染. 这种天然化合物在减轻 H. pylori 诱导的胃损伤方面表现有前途,为传统抗生素提供了潜在的替代品.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 自然产品化学 自然产品化学
背景情况:
- 杆菌是常见的慢性感染,通常无症状,由于抗生素的副作用,根除具有挑战性.
- 乌罗立B (UB) 是基酸 (EA) 的代谢物,具有抗炎,抗氧化和抗质性.
- 控制与H. pylori相关的胃病和宿主损伤是控制感染的关键策略.
研究的目的:
- 为了研究乌罗利B (UB) 治疗Helicobacter pylori感染的治疗潜力.
- 评估UB对H.pylori诱导的炎症和氧化应激的影响.
主要方法:
- 在体外和体外实验中评估了UB对H. pylori的影响.
- 使用了定量PCR (qPCR),ELISA,HE染色和IHC染色.
- 对比了UB的抗炎和抗氧化疗效与克拉里胺 (CLR) 和甲基醇 (MET).
主要成果:
- 在体外和体内,UB显著降低了H. pylori的粘附和殖民.
- UB改善了H. pylori诱导的炎症和氧化应激.
- 与CLR和MET相比,UB表现出优异的抗炎和抗氧化作用,也抑制了CagA分泌并减少了组织损伤.
结论:
- 乌罗立B有效地减轻了由H. pylori感染引起的损害.
- UB提供了一种有前途的天然化合物,用于管理与H. pylori相关的胃问题.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
451
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
451
01:26Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
465
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
465
01:30Peptic Ulcer Disease I: Introduction
197
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
197